Stay updated with breaking news from Arya Sciences Acquisition. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The slow pace of financing in med-tech appears to have stimulated cardiac arrhythmia technology developer Adagio Medical Inc. to turn to a special purpose acquisition company (SPAC) in a type of deal that has all but vanished in the last year. The company signed an agreement with Arya Sciences Acquisition Corp. IV to combine in a reverse merger deal that will result in Adagio’s listing on Nasdaq under “ADGM.”
By Sabela Ojea Arya Sciences Acquisition said Monday it is redeeming shares, as it won't consummate a business combination with a third party within the...
Perceptive Advisors Healthcare and biotech specialist Perceptive Advisors has raised four SPACs, and completed three deals. The firm's chief investment officer Adam Stone walked Insider through their SPAC strategy. The firm has taken Immatics, Cerevel Therapeutics, and Nautilus Biotechnology public via SPACs. Compared to the average SPAC sponsor, Perceptive Advisors' track record has been phenomenal. Less than a third of SPACs that took a target company public between 2015 and the summer of 2020 generated ...